Several but not all prospective studies have found high IGF-1 or IGF/IGFBP-3 ratio and high C-peptide to be associated with an increased risk of colorectal or colon cancer [12]–[19], [21]–[23]. The gene discussed is IGF1; the disease is malignant colon neoplasm.